EUVIMEDEUVIMED entdecken
Open Access

IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium

Stephen A Schworer, Kelly D Chason, Gang Chen, Jie Chen, Haibo Zhou, Allison J Burbank, Matthew J Kesic, Michelle L Hernandez

Journal of Allergy and Clinical Immunology · 2023

DOI: 10.1016/j.jaci.2023.01.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Stephen A Schworer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC; Marsico Lung Institute, University of North Ca…. Hauptthemen laut MEDLINE: Asthma, Enterovirus Infections, Picornaviridae Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Rhinoviruses (RVs) are the most common trigger for asthma exacerbations, and there are currently no targeted therapies for viral-induced asthma exacerbations. RV infection causes neutrophilic inflammation, which is often resistant to effects of glucocorticoids. IL-1 receptor antagonist (IL-1RA) treatment reduces neutrophilic inflammation in humans challenged with inhaled endotoxin and thus may have therapeutic potential for RV-induced asthma exacerbations. OBJECTIVE: We sought to test the hypothesis that IL-1RA treatment of airway epithelium reduces RV-mediated proinflammatory cytokine production, which is important for neutrophil recruitment. METHODS: Human bronchial epithelial cells from deceased donors without prior pulmonary disease were cultured at air-liquid interface and treated with IL-13 to approximate an asthmatic inflammatory milieu. Human bronchial epithelial cells were infected with human RV-16 with or without IL-1RA treatment. RESULTS: RV infection promoted the release of IL-1α and the neutrophil-attractant cytokines IL-6, IL-8, and CXCL10. Proinflammatory cytokine secretion was significantly reduced by IL-1RA treatment without significant change in IFN-β release or RV titer. In addition, IL-1RA reduced MUC5B expression after RV infection without impacting MUC5AC. CONCLUSIONS: These data suggest that IL-1RA treatment significantly reduced proinflammatory cytokines while preserving the antiviral response. These results provide evidence for further investigation of IL-1RA as a novel targeted therapy against neutrophil-attractant cytokine release in RV-induced airway inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaEnterovirus InfectionsPicornaviridae InfectionsHumansRhinovirusInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1CytokinesEpitheliumEpithelial CellsInflammation

Stichwörter der Autor:innen

AsthmaIL-13IL-1RAanakinraepithelial cellsexacerbationsrhinovirus

Substanzen

Interleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1Cytokines

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC.
  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC.
  • Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC. Electronic address: michelle_hernandez@med.unc.edu.

Förderung

  • NIEHS NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • NCATS
  • National Institutes of Health

Zitieren

APA

Schworer, S. A., Chason, K. D., Chen, G., Chen, J., Zhou, H., Burbank, A. J., Kesic, M. J., & Hernandez, M. L. (2023). IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.01.015

Vancouver

Schworer SA, Chason KD, Chen G, Chen J, Zhou H, Burbank AJ, et al. IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.01.015

BibTeX
@article{Schworer2023,
  author = {Schworer, Stephen A and Chason, Kelly D and Chen, Gang and Chen, Jie and Zhou, Haibo and Burbank, Allison J and Kesic, Matthew J and Hernandez, Michelle L},
  title = {IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  doi = {10.1016/j.jaci.2023.01.015}
}
Kostenlos starten →